Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis

CONCLUSION: The re-elevation of plasma EBV-DNA during EBV-HLH treatment poses challenges in determining disease status and treatment strategies. Optimal management decisions require a combination of the level of elevated EBV-DNA, the intensity of hyperinflammation, and the patient's immune function.PMID:38604242 | DOI:10.1016/j.jped.2024.03.006

Source: Jornal de Pediatria - April 11, 2024 Category: Pediatrics Authors: Wenzhi Zhang Yun Peng Yining Qiu Li Cheng Yuhong Yin Ying Li Lizhen Zhao Xiaoyan Wu Source Type: research